Actively Recruiting

Age: 18Years +
All Genders
NCT07441785

Immediate and Functional Results of Different Types of Reconstructions After Proximal Gastrectomy For Gastric and Esophagogastric Junction Cancer

Led by P. Herzen Moscow Oncology Research Institute · Updated on 2026-04-22

400

Participants Needed

1

Research Sites

230 weeks

Total Duration

On this page

Sponsors

P

P. Herzen Moscow Oncology Research Institute

Lead Sponsor

A

A.Loginov Moscow Clinical Scientific Center

Collaborating Sponsor

AI-Summary

What this Trial Is About

Proximal gastric and esophagogastric junction cancers comprise up to 40% of gastric malignancies. For localized disease, proximal gastrectomy is the main radical procedure, but reconstruction of GI tract often leads to significant functional issues. Rising use of proximal resections and broader indications have increased attention to postoperative quality of life (QoL). Common reconstructions include direct esophagogastrostomy (various types), double-tract reconstruction, jejunal interposition, and newer anti-reflux anastomoses (e.g., double-flap, overlap, tunnel techniques). Each method has unique pros and cons regarding reflux esophagitis, food passage, dumping syndrome, nutritional changes, and long-term QoL. No consensus exists on the optimal technique, leading to variable practices and outcomes. Most research focuses on oncologic radicality and survival, while functional results and QoL remain understudied. Systematic evaluation of functional outcomes across reconstruction types after proximal subtotal gastrectomy is needed in Russian Federation to improve QoL, advance research, and standardize treatment of proximal gastric and EGJ cancers.

CONDITIONS

Official Title

Immediate and Functional Results of Different Types of Reconstructions After Proximal Gastrectomy For Gastric and Esophagogastric Junction Cancer

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with clinically confirmed primary gastric or esophagogastric junction cancer (including Siewert Types II and III) cT1-3N0-2M0
  • Undergoing proximal gastrectomy with curative intent by open, laparoscopic, or robotic surgery
  • Surgery planned between January 1, 2025 and December 31, 2026
  • All consecutive eligible patients during this period
Not Eligible

You will not qualify if you...

  • Presence of metastatic disease or positive peritoneal cytology from prior staging laparoscopy
  • Diagnosis of Siewert Type I esophagogastric junction cancer
  • Emergency surgery or surgery without curative intent
  • Additional surgeries beyond curative surgery for primary esophageal or esophagogastric junction cancer
  • Previous surgery on the stomach or colon

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

P.Herzen Moscow Oncological Research Institute

Moscow, Russia

Actively Recruiting

Loading map...

Research Team

A

Andrey Ryabov, MD, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here